Cargando…
Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure
Hepatitis C virus (HCV) is a global pandemic, with nearly 200 million infected patients worldwide. HCV is the most common blood-borne infection in the US with numerous health implications including liver fibrosis, cirrhosis, and hepatocellular cancer. Traditional genotype-based HCV therapies with in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330188/ https://www.ncbi.nlm.nih.gov/pubmed/28260862 http://dx.doi.org/10.2147/DDDT.S130945 |